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CT             Computed Tomography 
MRI          Magnetic Resonance Imaging 
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ABSTRACT 
TITLE:  
ROLE OF MR ENTEROGRAPHY IN SMALL BOWEL DISEASES 
 
Presenting Author:   DR.R.RAJALAKSHMI 
                                  POST GRADUATE 
Co- authors:              PROF.DR.K.MALATHI 
Name of institution: BARNARD INSTITUTE OF RADIOLOGY, 
                                  MADRAS MEDICAL COLLEGE, CHENNAI 
 
AIM OF THE STUDY: 
The purpose of this study was to evaluate benefits of MR enterography in 
diagnosing and characterizing small bowel disease; Correlation of MR 
enterography findings with Histopathological reports and endoscopy findings; 
To assess the sensitivity and specificity of  MR enterography in diagnosing 
small bowel disease. 
 
 
METHOD OF STUDY 
Minimum 6 hrs fasting prior to the study; Metoclopromide tablet 20mg to promote 
gastric emptying; 1mg iv buscopan is administered just prior to the study to 
minimize movement artifact from peristalsis. Polyethylene glycol (PEG LEC) 
solution is prepared in 1.5 liters of water; Patient is instructed to drink the solution 
gradually for one hour for even distension of the entire small bowel and imaged on 
1.5 tesla MRI using abdomen coil in supine position & instructed for breathing 
instructions. 
 
RESULTS: 
Among 50 patients small bowel pathology is detected in 26 patients (52%) & no 
significant abnormalities in24 (48%) patients.  
Sensitivity- 92.30% & specificity-91.66% in diagnosing small bowel diseases. 
 
CONCLUSION: 
Cross-sectional imaging techniques are playing an increasing role in the evaluation 
of suspected small-bowel disorders, & growing awareness of the risks of radiation 
exposure has prompted the exploration of alternative imaging techniques.  
Advantages of MRI include lack of ionizing radiation, ability to provide dynamic 
information regarding bowel distention, motility, improved soft-tissue contrast, and 
a relatively safe intravenous contrast agent profile. 
KEY WORDS: 
Enterography, Enteroclysis, Intestinal tuberculosis, Crohn’s, Small bowel, 
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INTRODUCTION  
 
The small bowel imaging is difficult and challenging because of its 
positioning, length, and motility. For many years, the most common 
radiologic modality for evaluating small bowel diseases are  conventional 
small bowel follow through. Barium studies and endoscopy are the basic 
modalities in diagnosing small bowel diseases in their early stages with 
endoscopic guided biopsy and histopathological verification. But these 
studies did not provide extramural involvement of the disease and time 
consuming, involves radiation, and become tedious in performing the 
study in every patient with clinical suspicious of small bowel disease.  
 
Therefore there came the evolution of cross sectional imaging with 
CT in small bowel at most institutions due to its widespread availability, 
low cost and higher spatial and temporal resolution. With the 
development of multislice CT, imaging larger volume at faster speed and 
multiplanar reconstruction after the procedure makes CT a more 
convenient procedure for examining small bowel diseases. But the main 
disadvantage of CT is it is based on ionizing radiation hence the most 
preferable non ionizing modality MRI brought up into small bowel 
imaging for diagnosing and for follow up. 
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It has been reported in various studies that CT used for imaging 
crohns disease exposes the patient to high radiation doses.  A recent study 
stated that “CT accounts for up to 84.7% of the cumulative radiation in 
patients and that 15.5% of patients with Crohn disease received doses of 
more than 75 mSv.” (1). 
 
This has to be considered as patients with Crohns disease as they 
already have an increased risk for developing gastrointestinal cancer. 
 
As a result MR imaging methods developed for imaging small bowel 
diseases with advent of fast sequences like HASTE, Tru FISP. These 
sequences can be performed without artifact from peristalsis. Thus MR 
imaging of small bowel disease allows the imaging of both intra- and 
extra luminal disease and the complication of the disease without ionizing 
radiation and the risks associated with it. Even subtle 
disease manifestations may be detected when adequate distention of the 
small bowel is achieved. 
 
There are two techniques MR enteroclysis and MR enterography. 
Enteroclysis requires the placement of nasojejunal tube under 
fluoroscopic guidance and large volume of oral contrast is administered 
through the tube. 
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MR enterography patient is asked to drink the oral contrast for a 
particular length of time to get adequate distension of the bowel. 
 
Recent study done by Massaelli.G et. al, 2008 stated that “there is   
no significant difference between MR enteroclysis and MR enterography 
in the detection of small bowel diseases” (2). 
 
But the patients discomfort is very less in enterography compared to 
enteroclysis and patients acceptance highly favors MR enterography and 
many of the recent literature supports this fact. 
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REVIEW OF LITERATURE 
 
Small Intestine – Anatomy and Normal Appearances 
The small intestine is a tubular structure measuring approximately 
6m in length. The duodenum and jejunum constitutes approximately 40% 
of its length and the ileum contributes approximately 60% of its length 
and small bowel extends from the DJ flexure to the ileocaecal valve. DJ 
flexure is located by ligament of Treitz 
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The main function of small bowel is to receive and digest nutrients 
from the stomach and deliver the undigested residue to the large bowel. 
 
Small bowel loops are attached to the posterior abdominal wall by 
the small bowel mesentry which is broad fans shaped peritoneum fold. 
 
Root of mesentry is obliquely positioned extending from DJ flexure 
to right lower quadrant at ileoceacal junction. Jejunal loops are in the left 
upper and lower quadrant and ileal loops in the right lower quadrant. 
 
Small intestinal loops are normally in the partially collapsed state 
and when their maximal lumen diameter is less than 3cm it is considered 
as normal.  
 
Circular and spiral shaped configuration in the jejunal loops are 
valvulae convenientes and it is about 2mm thickness. It is seen in the 
proximal ileum and about 1mm thickness and absent in the terminal 
ileum characterizing featureless ileal loops. 
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VARIOUS DIAGNOSTIC MODALITIES 
 
PLAIN RADIOGRAPHY 
Plain radiographs remain the most commonly performed study in 
imaging world because of its availability, low cost and non- invasiveness. 
Perforation, bowel obstruction, pneumatosis intestanilis, foreign bodies 
remain the indication for plain radiograph in the small bowel 
investigations. 
 
SMALL BOWEL FOLLOW THOUGH 
Until the 1990’s for diagnosing small bowel diseases, the main 
modality available in radiology is small bowel follow through. Large 
volume of lower density barium is administered and succession of 
overhead films is used to monitor the barium progress. The appearance of 
barium in ceacum becomes an indication for flourosopy to demonstrate 
the terminal ileum. 
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For double contrast method, effervescent agents are given that 
release gas in the small intestine and can be used to give double-contrast 
views. 
 
Multiple views are available during the examination. Compression 
films are usually needed to visualize overlapping small bowel loops, to 
diagnose fixated loops. 
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The mucosal surface is better depicted in conventional barium 
studies and it also provides indirect information on disease extension 
inside and outside of the small bowel wall. 
 
The main disadvantage of barium follow-through is  
 Time consuming both for patients and the radiology department;  
 Use of ionizing radiation hence has the study is restricted 
particularly in children and pregnant women. 
 No major useful information given about extraluminal disease. 
Because of these factors barium study is being replaced by other 
modalities and cross sectional imaging. 
 
CONVENTIONAL ENTEROCLYSIS 
The main principle is to introduce the nasojejunal tube and to place 
its tip at duodenal jejunal flexure. Usually it is done under fluoroscopy. 
 
Then to administer the barium through the nasojejunal tube either 
manually or with the help of automatic pump. About 250 ml of barium 
sulphate is given followed by 0.5% methyl cellulose solution for a total of 
about 1500-2000ml. Complete adequate distension of bowel loops can be 
obtained with this method. 
9 
 
Sensitivity of conventional enteroclysis is 93.1% and specificity is 
96.9% and the study is found accurate in detecting mucosal lesions of 
small bowel disease, and also the study helps in the detection of small 
bowel obstruction 
 
Disadvantages of conventional enteroclysis 
 Nasojejunal intubation is highly discomfortable to the patients.  
 Radiation dose to the young patients 
 As like in the barium follow though very limited information about 
the extraluminal disease. 
 Overlapping bowel loops may lead to diagnostic difficulty.  
 Possibility of complications of intubation. 
 
Advantages of conventional enteroclysis 
 By introducing barium beyond gastric outflow regulations by 
pylorus barium can be directly introduced into the small bowel as rapidly 
as indicated. 
 Lumen distension is controlled by the rate of the infusion. 
 The examination is completed within 20 to 30 minutes which is 
very shorter when compared with barium follow though. 
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ULTRASOUND 
Ultrasound is a modality without radiation, with high accessibility 
and at low cost, but small bowel imaging using ultrasound is difficult. 
3.5–5 MHz transducer is used for abdomen and thereby small bowel 
ultrasound. Compression has to be given to displace bowel gas Target 
pattern and pseudo kidney pattern corresponds to thickened bowel wall.  
 
LIMITATIONS OF ULTRASOUND 
 The field of view is limited,  
 The technique is operator-dependent.  
 Less suitable technique for the follow-up(3).  
Ultrasound does not currently play a role in the diagnostic work-up in 
most of the small bowel diseases.  
 
CT 
With the advent of the multislice CT cross sectional imaging has 
almost replaced the conventional studies as CT has very fast scan rate, 
able to image the whole abdomen within few minutes, post processing 
techniques with multiplanar reconstruction, less discomfort to the patient. 
As the bowel loops are usually collapsed differerntiating bowel wall 
thickening from collapsed segments is difficult with CT without enteric 
contrast and iv contrast (4,5). 
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CT ENTEROCLYSIS 
 
 
NUCLEAR MEDICINE 
Nuclear medicine is a useful adjunctive imaging technique used to 
detect IBD. Leucocyte scintigraphy and FDG-PET used in diagnosing 
suspicious inflammatory bowel disease and also helpful in differentiating 
between active and inactive disease. 
  
Meta analysis study done to compare accuracy in detecting lesions 
found that no significant difference between scintigraphy, CT and MRI.  
(6). The drawbacks of leucocyte scintigraphy are the lower detection rate 
of extramural disease and the use of ionizing radiation (7). No data are 
available to suggest that leucocyte scintigraphy is indicated in patients 
with OGIB. 
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PET 
FDG (fluoro-2-deoxy-D-glucose) PET imaging is based on the 
detection of abnormal glucose metabolism hence it is a functional 
imaging modality. As FDG concentrates in the active inflammation, it can 
be used in detecting diseases that involve active inflammation.  
 
But PET currently is not used in Crohn’s disease as not all are active 
segments in crohns disease and showed increased FDG-uptake (8). The 
role of PET/CT in patients with OGIB has been evaluated only in patients 
with small bowel neoplasms(9). 
 
ENDOSCOPY 
Apart from the widely used ileocolonoscopy, which only allows for 
visualization of the terminal ileum, two other techniques are available 
that result in the visualization of a large part of the small bowel. 
 
ILECOLONOSCOPY 
After the routine colonoscopy, the terminal ileum is intubated and 
approximately 30 cm of the terminal ileum is visualized using this 
technique. 
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BALLOON-ASSISTED ENDOSCOPY 
It consists of an endoscope with one or several balloons attached By 
inflating and deflating the  balloon around the scope, almost the entire 
small bowel can be visualized. Tissue sampling for histological 
examination and the treatment of fibrotic strictures can be done with this 
technique. (10,11). 
 
The visualization achieved with this technique is comparable to 
standard enteroscopy; therefore, the technique can be considered the 
reference standard for imaging the small bowel.  
 
CAPSULE ENDOSCOPY 
This technique consists of a large capsule with a camera inside that 
takes two images of the bowel lumen every second for 8 hours (12). 
  
Several studies have reported promising results for capsule 
endoscopy in patients with Crohn’s disease and OGIB (13). In a meta-
analysis, capsule endoscopy was superior to other techniques. 
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CAPSULE ENDOSCOPY 
 
 
Only one study (14) compared capsule endoscopy with MR 
enterography in a small patient group with Crohn’s disease and OGIB 
without using a reference standard. This study revealed that capsule 
endoscopy diagnosed significantly more inflammatory lesions in the 
proximal and middle portion of the small bowel than MR enterography in 
patients with Crohn’s disease, and that capsule endoscopy was also 
superior to MR enterography in patients with OGIB. 
 
So far, no head-to-head comparison studies have been performed 
concerning MR enteroclysis, which has important advantages over other 
imaging techniques than MRI, such as an unlimited multi-planar field of 
view, reproducibility, and no ionizing radiation. 
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PUSH ENTEROSCOPY 
Push enteroscopy is mainly for visualizing jejunal loops. The scopy 
is introduced upto DJ flexure and introduced further like colonoscopy 
technique. Overall yield of diagnosis with push enteroscope is 53%. 
 
SONDE ENTEROSCOPY 
Sonde enteroscopy has a very long (290cm) , thin (5mm), flexible 
endoscope wire and it can passed into the small bowel with the help of 
peristalsis. So it takes many hours (nearly 8 hours) to visualize the entire 
small bowel. This procedure is cumbersome and obsolete now. 
 
INTRAOPERATIVE ENTEROSCOPY 
It is usually performed at the laprotomy procedure or through the 
enterostomy sites. It requires the instruments like colonoscope, push 
enteroscope,  and video processor. It is done in patients with occult gi 
bleeding and source could not be identified with any modality. 
 
MRI 
MRI is an imaging modality with high contrast resolution of soft 
tissue without using ionizing radiation and also having multiplanar 
imaging. Due to the development of shorter scanning techniques, e.g. 
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single shot techniques, the entire small bowel can be visualized without 
artifacts caused by small bowel peristalsis and respiration movements. 
 
MRI can evaluate features like bowel wall thickness, wall 
enhancement, bowel wall oedema, ulceration, perimural infiltration, and 
lymph node evaluation, contrast enhancement, adhesions, strictures, 
fistula, perianal fistulas, abscess, bowel obstruction, all of which are 
important features to be observed in small bowel disease and MRI is a 
single stop to visualize all these findings.(15,16).  
 
As most of the small-bowel diseases manifest earlier in life and 
persists as a long term condition, patient suffering from small bowel 
disease has to undergo multiple radiological/ endoscopic interventions to 
see for any progression of the disease or response to therapy and to look 
for any complications. MR enterography is a boon to these kind of 
patients as it has no radiation risk and non invasive procedure.  
 
ADVANTAGES 
 Most important is MRI do not use ionizing radiation.  
 Tissue contrast is superior in MRI than that of CT.  
 Intravenous contrast material for MR imaging has a good safety profile 
and MR enterography with contrast can be used in patients  in whom 
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CT with i.v contrast cannot be taken like patients with allergic 
reactions to CT iv contrast and patients with elevated serum creatinine. 
 Gadolinium i.v contrast is not necessarily as lots of abnormalities can 
be detected with MRI without the need of iv contrast. This is great 
benefit to pregnant patients,  patients with renal failure and low GFR 
and patients with possibility of risk of developing nephrogenic 
systemic fibrosis. 
 
LIMITATIONS OF MR IMAGING 
 Cost of the study, 
 Claustrophobia 
 Spatial and temporal resolution is comparatively lower in MRI than 
CT. 
 Some patients may difficulty in breath hold. 
 
MR ENTEROCLYSIS 
 MR enteroclysis is a technique in which nasoenteric tube is placed at 
DJ flexure using fluoroscopy before MR enteroclysis is begun.  
 Then mannitol 3% solution is administered though the tube either via 
manual injection or automated pump or MR compatible infusion 
device. Then the patient should be immediately transferred to MRI 
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room for scanning or mannitol infusion can also be done in MRI 
scanning room. 
 Contrast is infused at a rate of 80 mL/min and flow rate is adjusted 
according to the bowel distension. 
 First sequence to be applied is coronal balanced SSFP images as a 
scout image and to assess the adequacy of bowel distension and to see 
whether contrast has reached ileoceacal junction. 
 Then after giving breathing instructions axial and coronal sequences 
are applied alternatively.   
 Then contrast-enhanced sequences also performed similarly.  
 
MR ENTEROGRAPHY VS MR ENTEROCLYSIS 
MR enterography is a technique in which large volume of oral 
contrast is given per oral for a particular period of time instead of 
nasojejunal intubation as in MR enteroclysis.  
In a study done by negaard et al and frokjaer et al patients 
acceptance is favoring MR enterography than enteroclysis (17,18).  
Another prospective study done by negaard et al showed that 
enterography and enteroclysis has similar sensitivity in diagnosing active 
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inflammation in crohns. The study done by Schreyer et al also shown the 
same sensitivity for MR enterogrpahy and enteroclysis. (19,20).  
Masselli et al in his prospective study done at 2008 said that mucosal 
abnormalities are better shown in MR enteroclysis than MR 
enterography. (2).  
But masseli in his same study said that better distension of bowel 
may be in enteroclysis but that could not be translated as better diagnostic 
accuracy(2). 
Many other articles revealed the fact that patient acceptance is far 
better in MR enterography than MR enteroclysis. 
 
ORAL CONTRAST AGENTS 
There are several oral contrast agents that can be used for MR 
imaging. Three categories based on signal onT1- and T2-weighted 
images:  
 High signal intensity on both T1 &T2- Positive contrast agents, 
 Low signal intensity on both T1 &T2 - Negative contrast agents,  
 High signal intensity on T2 and low signal on T1 images- Biphasic 
contrast agents.  
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Most of the available oral contrast agents are biphasic category. 
Mannitol and PEG are the oral contrast agents most commonly used. 
Filder et al, desmond at al evaluated different contrast agents, like 
water, mannitol, polyethylene glycol, osmotic and nonosmotic agents and 
found no significant difference between the agents in imaging values but 
each has unique charectistics and limitations (21,22,23).  
Lots of algorithm suggested for the protocol of oral contrast 
ingestion but the basic view is to large quantity of oral contrast solution 
to be taken during one hour. 
Studies done by boraschi et al, faber et al, herrmann et al, laghi et al 
mainly concentrated on the preferred oral contrast agents and mainly on 
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negative contrast agents like oral magnetic particles, perfluorooctyl 
bromide, ferumoxide. (24–29).  
These study results are bowel wall inflammation usually causes high 
signal intensity on T2 weighted images, if the bowel lumen is dark in T2 
with negative oral contrast solution, there will be a great contrast between 
dark bowel lumen and bright wall inflammation. Interbowel loop abscess 
also better picked up with negative contrast agents. 
Study done by laghi et al and reiber et al mainly on the positive 
contrast agents. They are ferrous ions, manganese ions, gadolinium 
chelates, (27,28). Karantanas et al studied bluberry juice as positive oral 
contrast. Other food items like milk, vegetable oil, green tea, can be used 
as enteric contrast agents(29). Contrast between wall thickening and 
lumen is seen in T1 weighted images but contrast enhancement on T1 
images are not well depicted.  
 
PEG SOLUTION AND REGIMEN: 
45 mg reconstituted in 1 liter of which the patient takes 1.5-2 l 
(depending on the patient tolerance) commencing approximately 45-60 
min before imaging. The patient takes 1-1.5 l in the first 30 min and then 
250 ml every 15 min. Immediately before imaging, the patient has to 
drink approximately 500 ml of water. This regimen permits the 
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evaluation of the entire small bowel in slow intestinal transits, and the 
water administered on the MR table allows for the scanning of the jejunal 
loops in rapid intestinal transits, where the passage to the colon may 
result in poor small bowel distension. 
This regimen is well tolerated. According to herraiz hidalgo et al 
there are virtually no adverse effects and less than 5% of their study 
patients had intestinal discomfort or moderate diarrhea for several hours 
after the examination. 
There are similar results for this PEG regimen and reported in many 
papers.(30,31,32)  
Most important issues regarding oral contrast administration are the 
volume of contrast and the timing of administration. 
There is a wide range of interpersonal variability in transit times, 
between patients. (with the exception of patients with obstruction).  
Using PEG, the average time the column of contrast takes to reach 
the cecum varies from 20 to 240 min, with an average time of 55---65 
min.(31).  
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RECTAL CONTRAST ADMINISTRATION 
Studies done by narin et al and ajaj et al stressed that contrast given 
per rectum to distend large bowel will be better in lesion detection. 
Especially in crohns disease combination of enterography with 
colonography is better imaging technique and it is supported by studies 
done by Schreyer et al and herrmann et al. (20,26 ,33,34). But colonic 
abnormalities may be well shown with antegrade filling without rectal 
contrast need. 
PATIENT POSITIONING 
Cronin et al done a study in 2008 comparing prone vs supine 
positioning in patients undergoing MR enterogrpahy, may be imaged in 
either the supine or the prone position. Separation of small-bowel loops 
from the pelvis is noted in prone position but it is not necessarily needed. 
(35). 
 
SPASMOLYTICS AND GASTRIC EMPTYING 
Bowel peristalsis causes artifacts in imaging mainly in the gradient 
echo sequence. HASTE sequence which is a fast heavily T2 weighted 
sequence is particular for intraluminal flow artifacts due to intraluminal 
air. Contrast VIBE 3D sequence is also more prone for artifacts due to 
motion. 
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Spasmolytics helps in reducing the peristalsis and thereby reducing 
motion artifacts. 
The commonly used spasmolytic is 20 mg intravenous buscopan 
(hyoscine –N- butylbromide). Contraindication for buscopan like acute 
angle glaucoma, cardiac arrhythmia should be ruled out. 
Some studies revealed that two divided dose of glucagon 0.5 mg  
initially subcutaneously before starting the study and later 0.3 mg 
intravenously before contrast sequence is applied. 
Few studies mentioned 1mg intravenous glucagon just before 
contrast sequence is applied. 
For gastric emptying metaclopramide suspension 10mg suspension 
is given. 
 
INTRAVENOUS CONTRAST MATERIAL 
Study done by Low RN et al showed correlation between gadolinium 
enhanced sequences and endoscopic findings. In his study he 
demonstrated contrast enhancement in bowel wall, perienteric 
hyperenhancement suggests active inflammation in crohn’s disease and it 
is also useful for detecting enhancement in lymphnodes and mass lesions. 
(36–38).  
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Dose for gadodiamide is 0.2 mmol/kg and given at the rate of 3ml 
per second, scanning should start after 45 seconds. 
There are many researches ongoing in the field of perfusion imaging 
for small bowel diseases. 
Intravenous contrast is not mandatory for MR enterography and 
pattern of wall thickening and surrounding inflammation and signal 
characteristics in T2 weighted images also helps in diagnosing active 
inflammation. Gadolinium contrast helps in better characterization of the 
lesion. 
Many researches are ongoing to determine the availability and utility 
of perfusion imaging of the bowel for evaluation of inflammatory bowel 
disease.   
SEQUENCES 
 
Multiple sequences are needed for the study of MR enterography 
hence limitations of each sequences are compensated. 
There is no generalized protocols for MR enterography but the 
routinely used sequences are T2-weighted sequences like HASTE and 
balanced SSFP. 
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HASTE (ULTRA FAST SPIN ECHO SEQUENCE)  
HASTE (half Fourier single shot turbo spin echo sequence) 
sequences are breathing independent T2 weighted sequence. 
 Not sensitive to patient motion or respiration hence used in 
uncooperative patients. 
 Susceptibility insensitive 
 Not much detailed view of bowel wall. 
 These sequences are very much sensitive for motion 
particularly intraluminal air motion. And produces low signal 
intensity artifacts within bowel lumen.  
 
BALANCED SSFP 
Balanced SSFP images is a gradient sequence and it is a very fast 
sequence and it is called as TruFisp in Siemens machine and FIESTA 
(Fast imaging employing steady state acquisition) in GE machine  
This sequence has a  
 Very high signal to noise ratio and  
 Good T2/T1 weighted image contrast. 
 Displays fluid homogenously. 
 Susceptibility sensitive 
 Any motion causes heavy artifacts with signal loss. 
 Black boundary artifact is seen. 
27 
 
 Better demonstration of mesenteric vessels and 
lymphadenopathy than HASTE sequence. 
 
Fat suppression is needed for better depiction of lesion as lesions are 
hyperintense in T2 weighted sequence and it will be better seen if 
perienteric fat is suppressed using fat suppression technique (37). Bowel 
wall is better seen in fat-suppressed TruFisp images than fat-suppressed 
HASTE images. Fat suppression technique eliminates black boundary 
artifacts 
 
Contrast- sequence is applied either two- or three-dimensional 
acquisitions.  This sequence has a lengthy volumetric acquisitions, hence 
blurring may occur due to wall motion. 
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CINE MRI EVALUATION OF BOWEL – 
 MR FLUOROSCOPY 
 One of the earliest sign in inflammatory bowel disease is 
decreased peristalsis in the diseased segment of bowel loop. 
 Standard MR enterography is based on static imaging. 
 There is a new technique of real time cine MRI with this bowel 
peristalsis can be visualized. 
 The sequence used for cine MRI is thick slab coronal balanced 
steady state sequence with 10mm thickness of abdomen and 
continuously imaged for peristaltic evaluation. 
 This is also used to check whether the oral contrast have reached 
the ileoceacal junction. 
 
Study done by waldehrr et al compared cine MRI and conventional 
MR enterography in 40 patients who are known case of crohns 
disease.(57). The findings are described as areas of abnormal motility 
increased or decreased  peristalsis when compared with normal bowel. 
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Results of the study are  
 Cine MRI find more number of abnormal segments than 
standard static MR enterography. 
 The author confidently depicts that bowel dysmotility is 
earliest sign of inflammatory bowel disease. 
 Limitation of this study is there is no histological or 
endoscopic correlation of cine imaging findings  
 
DIAGNOSTIC QUALITY OF BOWEL DISTENSION 
 
Rakesh sinha et al at 2013 done a study on the impact of divided oral 
contrast ingestion on bowel distension and quality of images in MR 
enterography (58). 
 
As adequate distension is imminent for the successful study patient 
compliance, timing of imaging, amount of contrast ingested is important. 
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THREE GRADES IN MR ENTEROGRPAHY: 
 
 Grade 3: All the bowel loops are well distended. -confident 
diagnostic study. 
 Grade 2: Few bowel loops are less distended and remaining are 
well distended and opacified, - diagnostic study 
 Grade 1: Most of the bowel loops are unopacified hence non 
diagnostic study. 
 
For grading measurement should be done at axial TruFi images 
with fat suppression. Fat suppression is needed to eliminate black 
boundary artifact. Measurements should be taken at normal bowel 
segments as there may be alterations due to bowel mural wall thickness in 
diseased portions. Three measurements are taken at ileum, jejunum and 
ceacum and average of three values should be taken. 
 
Results of this study are 
 Bowel diameter more than 1.95cm are in the grade 3 quality 
and best for diagnostic interpretation. 
 Most of the patients have grade 3 distension with divided dose 
preparation. 
31 
 
 Suboptimal distension with poorer image quality in standard 
dose preparation. 
 Increasing bowel diameter and diagnostic image quality has 
strong positive correlation. 
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MRE PERFORMANCE CHARACTERISTICS 
There are many studies that depicts the performance characteristics 
of MR enterography.  
 
Study done by Foriano et al clearly stated that CT and MR 
enterography had similar efficacy in identifying disease localization, 
bowel wall thickening, enhancement identifying fistula and 
lymphnodes(59). 
 In this study, MRE is more sensitive in identifying stricture 
than CTE and MRE having slightly more sensitivity for bowel 
wall enhancement than CTE, 
 Sensitivities and specificities of MR enterography for small 
intestinal manifestations in crohns disease were similar to 
other reported studies with 0.88 (0.78-0.99, CI 95%) 
sensitivity and 0.88 (0.68-1.0, CI 95%) specificity. 
 Enteroenteric fistula identification  was almost similar 
between CTE and MRE (0.04 vs 0.02; p=0.08), respectively.  
 This study concluded that both CT and MR enterography are 
highly effective modalities in assessing ileocolonic Crohn's 
disease and having similar accuracy. 
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Another study done by Jensen et al (60) compared image quality 
and also disease evaluation in CT and MR Enterography.  
 He stated that CT has a better image quality because of little 
motion artifact due to fast acquisition.  
 Inter-observer agreement for disease evaluation, was high for 
CT and moderate for MR enterography.  
 In this study it was also found that disease evaluation of small 
bowel is both observer and modality dependent. 
 Both techniques had comparable diagnostic yields inspite of 
the difference.  
 He concluded that MR enterography is an acceptable 
alternative to CT enterography. 
 
Ilangovan et al (61) stated in his study that CT enterography 
compared with MR enterography had good superior spatial and temporal 
resolution, and CT had fast single breath-hold examination.  
 He also mentions that CT is cheaper and more available than 
MRI enterography, shorter examination times for CT. 
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 But he states that contrast resolution is superior in MRI and 
demonstrating fistulae is better in MRI than CT.  
 Gadolinium-based intravenous contrast used for MR 
examination is safer than the iodinated contrast used for CT.  
Meta-analysis study done by Horsthuis et al (6) and  Siddiki et al 
(46) “ Both small bowel CT and MRI had similar diagnostic 
performance; Of course, the radiation exposure with CT is a disadvantage 
compared with MRI” 
 
A cohort study done by Masselli et al recently compared MR 
enterography and MR enteroclysis in Crohn’s disease. (2).  
 This study showed that bowel distention and mucosal bowel 
abnormality better depicted in MR enteroclysis.  
 Detection of luminal narrowing, fistulae are similar in both 
MR enterography and enteroclysis. 
 MR enteroclysis may be preferable modality for Crohn’s 
disease evaluation but MR enterography is an acceptable 
alternative in those unable to tolerate nasojejunal intubation.  
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COMPARISON OF MRI WITH OTHER IMAGING 
MODALITIES: 
The MRI protocol most frequently compared with other modalities 
has been MR enterography. A number of recent prospective studies have 
demonstrated MR enterography to be at least comparable to other 
imaging modalities for detection of small bowel disease in Crohn’s 
patients.  
 
A study done recently by Francis et al compares contrast-enhanced 
MR and CT enterography in Crohn’s disease. This study found that for 
detection of subtle small bowel inflammatory changes MRI is better than 
CT. (62).  
 
Comparison of MR enterography with fluoroscopic barium small 
bowel series done in a study conducted at 2005 by Greenberg et al (63).  
 Patients (30 subjects) who are known case of crohns disease 
underwent both MR enterography and small bowel series on 
different days and comparison between these modalities done. 
 The study results are 60% of study both study has concordant 
results. Remaining 40% of subjects with discordant results, 
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SBFT demonstrated additional findings in 12% of cases, and 
MRI found additional information in 27% of cases by 
demonstrating active inflammation. But no histological or 
endoscopic comparison was included in this study.  
 
A study conducted by Kim et al in 2009 compared 4 modalities 
MR enterography and CT enterography, barium SBFT and 
ileocolonoscopy (64) in each patients who are known cases of crohns 
disease (30 subjects). 
 Both CT and MRI has better accuracy in detection of 
extramural complications of crohns like fistulae, sinus tracts, 
abscesses than barium SBFT.  
 Both CT and MRI also demonstrated more segments of active 
bowel wall inflammation proximal to the terminal ileum than 
SBFT. 
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Another study done in 2009 by Fidler et al compared MR and CT 
enterography in patients with suspicious of crohns disease and they used 
ileocolonoscopic as reference standard. The sensitivity in detecting active 
small bowel inflammation obtained by MR enterography is 90.5% and by 
CT enterography is 95.2% and it is almost similar and comparable. (21). 
 
Wireless capsule endoscopy (WCE) is a minimally invasive 
technique for small bowel evaluation(65). The patient has to swallow the 
capsule endoscope and it is propelled by peristalsis and captures images 
of the small bowel which is stored in a recorder. It provides small bowel 
endoluminal information. Major advantages is it can detect subtle 
mucosal abnormalities. Limitations are it cannot be given in patients with 
stricture and extraluminal lesion cannot be visualized.  
 Only limited studies available for comparison of MR 
enterography and wireless capsule endoscopy. One study 
compared MR enteroclysis with wireless capsule endoscopy in 
patients with suspected small bowel disease with a sample size 
of 15 patients. In this study there is no correlation with HPE. 
 This study showed that capsule endoscopy shows more 
number of lesions in jejunum than MR enterography and no 
difference in lesion detection in the region of terminal ileum. 
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MRI shows extraluminal complications very well in all the 
patients. 
 
In a large meta analysis study done at may 2010 by Ingrid 
markova et al (71) which compares various modalities like CT, CT 
enteroclysis, CT enterography, USG, contrast enhanced ultrasound, MR 
enterography, MR enteroclysis, small bowel follow through, conventional 
enteroclysis, various endoscopic techniques like ileocolonoscopy, push 
enteroscopy, sonde enteroscopy, wireless capsule endoscopy, double 
balloon enteroscopy, intraoperative enteroscopy. This study submitted its 
results as follows 
 Small bowel follow through has only secondary role in 
imaging. 
 For children ultrasound is the preferred modality 
 Conventional enteroclysis is replaced by the cross sectional 
imaging. 
 CT and MR enterography is preferred by most authors and 
they strictly not needed the intubation procedure under 
fluoroscopic guidance. 
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 MRI is found to be more sensitive than CT in diagnosing 
small bowel inflammatory diseases. 
 CT or MR enterography is the preferred modality for follow 
up examinations 
 CT/MR enterography or CT/MR enteroclysis are more 
sensitive in diagnosing small bowel tumors. 
 Wireless capsule endoscopy is the better investigation for 
detecting mucosal abnormalities in patients with obscure g.i 
bleeding. 
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COMPARING ENDOSCOPIC AND RADIOLOGICAL 
PROCEDURES (MR ENTEROGRAPHY) 
RADIOLOGICAL PROCEDURES: 
 Minimally invasive to the patients 
 It shows entire imaging of the small bowel 
 Doesn’t have radiation exposure 
 Takes less time to complete the procedure 
 
ENDOSCOPIC METHODS: 
 It is invasive and more cumbersome to the patients 
 Has the complications of the invasive procedure 
 Depends on the doing persons technical skill. 
 Takes long time to finish 
 Expensive than most of the radiological procedures 
 But has advantage of taking biopsy from the lesions 
visualized. 
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CT VERSUS MR ENTEROGRAPHY:  
CT ENTEROGRAPHY (COMPARED WITH MR ENTEROGRAPHY) 
- Technically more robust and easy 
- Short examination time 
- More accessible 
- Higher technical and interpretive reproducibility 
- Works better for acute, severe, complex, and emergent cases 
- Less expensive 
- Causes radiation exposure 
 
MR ENTEROGRAPHY (COMPARED WITH CT ENTEROGRAPHY) 
- Technically more difficult 
- Long examination time 
- Less accessible 
- Better suited for organ specific and disease specific (e.g. 
Crohn's disease) evaluation 
- May not work well for acute, severe, complex, and emergent 
cases 
- More expensive 
- No radiation exposure 
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NEWER TECHNIQUES: 
EMERGING ROLES OF MRI IN INFLAMMATORY 
DISEASE: 
 
TECHNICAL ADVANCES IN MRI: 
 There is a lot of technical advancement in MRI like higher 
magnetic field, motion artifact reduction techniques, parallel 
imaging processing, shorter scan times. 
 Due to the advent of these there is increased spatial resolution in 
detection of subtle bowel changes.  
 With these developments MRI will become a surveillance tool in 
small bowel imaging replacing CT and other invasive procedures. 
 MR Fluoroscopy and MR Perfusion are the emergent techniques 
that attracts lot of attention. 
 Scoring of disease activity in crohn’s disease also an upcoming 
area. 
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DETECTION OF MURAL FIBROSIS: 
 The main role of imaging in crohns is differentiating active from 
inactive disease. For that the detection of mural fibrosis came into 
play. 
 If active inflammatory bowel segment is found in imaging patient 
has to be started in disease modifying therapy, but if inactive 
mural fibrosis is detected on imaging it indicates the last 
irreversible stage of the disease and patient is switched to surgical 
treatment for resection of the fibrosed segment if needed.  
 Mural fibrosis is the collagen deposition in the submucosal and 
serosal layer and it causes marked luminal narrowing and 
proximal dilatation of the bowel hence the need of surgical 
management. 
 It is important to differentiate between mural fibrosis and 
stricture caused by active inflammation. MRI features of mural 
fibrosis are T2 hypointensity in segment of bowel wall with lack 
of contrast enhancement.  
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COMBINATION OF MR ENTEROGRAPHY AND MR 
COLONOGRAPHY: 
 Single protocol that combines both MR enterography and 
colonography will be very helpful for evaluation of small and 
large bowel at a single study especially in the patients with 
crohns disease. 
 Study done in 2005 followed a protocol that combined both  
enterography and colonograhy. In that study done in known case 
of crohns they gave 1.5 liters of oral contrast and 750ml to 1 liter 
of enema. They done this study in 20 patients and in another 20 
patients they carried out the standard enterography protocol 
without enema. They compared the study with scopy findings. 
 In this study they clearly showed that administration of enema 
more lesions are found out than standard enterography protocol. 
 But the major issue is patient’s compliance. Many patients felt 
uncomfortable and distended. Giving additional rectal contrast is 
less acceptable by the patients. The study mentioned that 
distending the large bowel by oral contrast and scanning with 
delayed time is more preferred and ideal examination. 
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MRI AS A BIOMARKER FOR THERAPEUTIC RESPONSE: 
 Inflammatory bowel disease treatment has been changing by the 
introduction of molecular pathway targeting therapies. Some of 
proinflammatory cytokines involved in inflammatory bowel 
diseases are CTLA-4, CD20, TNF -α, α4 integrin molecules. (66) 
 When patients are refractory to the standard treatment for 
inflammatory bowel disease these biological agents are 
considered for treatment and they are found to be more specific 
treatment. Some of the agents that are in current role are 
chimeric antibodies, recombinant peptides. These molecules are 
very costly and having many unique side effects and used only 
as a last therapeutic approach. 
 There is a need of frequent assessment of response at each time 
administering the biomolecule and MRI is well served as a 
biological marker for assessing therapeutic response.  
 It is highly beneficial for the patients to avoid potential side 
effects by the biomolecules by an early imaging assessment of 
treatment response or failure.  
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NEW SEQUENCES AND TECHNIQUES 
 
DIFFUSION-WEIGHTED MRI 
Restricted diffusion in the bowel wall segments signifies active 
disease. Four retrospective studies based on diffusion weighted sequence 
conducted and proved this with a variety of reference standards(67).  
 
MOTILITY IMAGING 
Fast T2-weighted cine sequences are used for assessing small bowel 
motility. This can be attained in a single breathhold. Qualitative 
assessment of bowel motility can be assessed with this imaging. Cine 
MRI study conducted in a group found more crohns disease cases than 
compared with standard protocol (68,69). 
 
MAGNETIZATION TRANSFER IMAGING 
There was a study which compared magnetization transfer ratio and 
tissue collagen level in crohns disease, and found to have linear relation 
between them (70). 
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MRI SCORES OF DISEASE SEVERITY 
  
    If disease severity is given in scores, it will be helpful to compare 
for the disease progression and response to treatment and also helpful in 
comparing with other patients. Some of the indices that are in clinical 
trial for scoring disease activity are HBI, CDEIS, CDAI. 
 
RUTGEERTS SCORE: 
 A study conducted in 2008, (70) MR enteroclysis and 
ileocolonoscopy done in patients with suscpicion of disease recurrence 
with study sample of 30 patients. Rutgeerts score was obtained. This 
score ranging from 0 to 3, in which 0 means normal and score of 3 means 
active disease recurrence. MRI features that gives score of 3 is definite 
bowel wall thickening, enhancement of the bowel wall, perimural fat, 
high grade bowel obstruction, fistulas, abscess, T2 signal characteristics. 
 
In this study the results showed good correlation between MRI 
scoring and ileocolonoscopic findings (κ = 0.67). This scoring system had 
good similar results when done with many other radiologists (κ = 0.89). 
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MAGNETIC RESONANCE INDEX OF ACTIVITY (MARIA): 
Another scoring system developed called magnetic resonance index 
of activity (MaRIA). MaRIA score was calculated by comparing MRI 
findings and CDEIS. 
 
“Wall thickness (p = 0.007), relative contrast enhancement (p = 
0.01), mural edema (p = 0.02), and ulceration at MRI (p = 0.003) were 
independent predictors of segmental CDEIS. On the basis of  regression 
model, the authors proposed a simplified MaRIA score per segment: 1.56 
× wall thickness in millimeters + 0.02 × relative contrast enhancement + 
5 × edema + 10 × ulceration.”  
 
Mucosal ulceration is the important component of the MaRIA 
scoring system. This scoring system has a significant correlation with the 
segmental CDEIS (r = 0.81, p < 0.001). By adding individual segmental 
scores total Ma-RIA score was obtained and found to have significant 
correlation with many of the parameters like  total CDEIS score (r = 
0.78), HBI (r = 0.56), CRP concentration (r = 0.53).  
 
The same author again(70) conducted the same study in a new group 
of 48 patients and proved his study values again using same MRI 
protocol.  
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CDA SCORE: 
Another new scoring system for disease activity is Crohn Disease 
activity (CDA) score. This score was correlated with histopatlological 
findings of disease activity. This score also found to have good 
qualitative scoring of disease activity.   
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AIM OF THE STUDY 
 
 The purpose of this study was to evaluate benefits of MR 
enterography in diagnosing and characterizing small bowel 
disease.   
 
 Correlation of MR enterography findings with 
Histopathological reports and ileocolonoscopy findings. 
 
 To assess the sensitivity and specificity of  MR enterography in 
diagnosing small bowel disease and to assess sensitivity and 
specificity in detecting crohn’s disease. 
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METHODOLOGY 
STUDY CENTER 
The study was done in Barnard Institute of Radiology, Rajiv 
Gandhi Government General Hospital, Chennai 
SAMPLE SIZE:    50 patients 
STUDY PERIOD: 6 months (March 2014 to August 2014) 
STUDY DESIGN:  Prospective observational study 
INCLUSION CRITERIA 
Patient of any age  
Presented with strong clinical suspicious for small bowel disease 
Suspected to have partial, low grade small intestinal obstruction, 
Suspected to have small intestinal tuberculosis 
Suspected to have inflammatory bowel disease, 
Patients having unexplained abdominal pain, 
Patients having chronic right iliac fossa pain 
Patients having history of malabsorption. 
Patients having unexplained gastrointestinal bleeding. 
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EXCLUSION CRITERIA 
Patient with general contraindication for MRI 
Patient with total bowel obstruction 
Patient with acute symptoms 
Patient with severe vomiting 
Sick patients  
Patient who are not given the consent for the study. 
These patients are not included in the study group. 
 
MR ENTEROGRAPHY PROTOCOL 
Patients who were admitted in the ward who presented with clinical 
findings and symptoms suggesting of small bowel disease were enrolled 
in the study.  A written informed consent was obtained from the patient 
before enrolment into the study. The clinical history regarding present 
history was taken in the prescribed proforma. Other investigations if 
already done like usg abdomen, CT abdomen findings, scopy findings are 
noted down. 
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BOWEL PREPARATION 
Patient should be instructed to minimum 6 hrs fasting prior to the study; 
Patient can take liquid food like juices at this time. 
No laxatives or enema administered prior to the study. 
Patient is asked to arrive one and half  hour before the examination. 
 
ORAL INGESTION PROTOCOL 
DIVIDED DOSE PREPARATION 
On arrival at the radiology department, patient was asked to drink 
1200-1500 ml PEG solution over 50 min.  
Polyethylene glycol (PEG LEC) solution is prepared by dissolving 9 
mEQ of PEG with electrolytes & flavoring agents which is commercially 
available as PEG LEC 70 grams of powder in 1.5 liters of water 
The oral contrast material was divided into two portions, and 
instructed to drink each portion in 25 minutes.  
10 mg of oral metoclopromide suspension for promoting gastric 
emptying is given with the first portion.  
To opacify stomach and duodenum  just before imaging, patients 
instructed to have another 200 ml of oral contrast. 
54 
 
Patient is instructed to drink the solution gradually for even 
distension of the entire small bowel. 
One hour after the commencement of oral contrast ingestion patient 
is imaged on 1.5 Tesla MRI (Magnetom Avanto; Siemens, Erlangen, 
Germany) using phased array abdomen coil in supine position. 
Patient is instructed for breathing instructions. 
Before running the sequences 1mg of i.v buscopan is given to 
minimize movement artifact from peristalsis. 
Images are obtained and evaluated. 
Results are followed up with clinical follow up and histo 
pathological findings. 
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PROTOCOL 
 
  
SEQUENCE 
T2 
TruFis
p 
T2 
TruFi
sp 
T2 
TruFis
p 
T2 
HAST
E 
T2 
HAST
E 
T1Flas
h 
pre/pos
t Gd 
       
ORIENTATION coronal axial sagital coronal axial coronal 
SCAN TIME 20 sec 22 sec 13 sec 30 sec 50 sec 2 min 20 s 
SLICES(mm) 24 23 17 24 23 72 
THICKNESS(mm) 5 7 7 5 7 2 
GAP(mm) 0 7 7 0 7 .4 
TR(ms) 3.34 2.83 2.83 124 128 3.52 
TE(ms) 1.38 1.2 1.2 93 97 1.16 
AVERAGES 1 1 1 1 1 1 
MATRIX 192x156 
166x1
56 
166x15
6 
218x25
6 
166x15
6 
230x25
6 
FLIP ANGLES 60 70 70 150 150 12 
MEASUREMENT 1 1 1 1 1 2 
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OBSERVATIONS 
The studies were carried out on 50 cases with small bowel 
indications and the following observations are made. 
 The total examination time  averagely of about 5.0 minutes (within 
the range of 3.5 to 10 min).  
 Most of the patients are comfortable with drinking oral contrast 
solution and only two patients had minor side effects during drinking. 
One patient vomited at the end of the drinking oral contrast solution and 
another patient had a minor diarrhea while drinking the solution. But both 
patients settled and managed to complete the study. 
 In one patient the study could not be completed at first attempt as 
in that patient contrast material did not reach the terminal ileum as a 
result of incomplete bowel preparation. After bowel preparation patient 
was asked to come on another day and study was completed. 
 There were no artifacts caused by motion in TruFisp sequence and 
study interpretation in TruFisp sequence is not affected by motion in any 
of the patients 
 One patient had a susceptibility artifact in TruFisp sequence. 
 In three patients, artifacts due to small bowel peristalsis is seen in  
FLASH 3D T1 contrast sequence but there is no problem in analyzing the 
bowel wall enhancement in these patients. 
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 Normal small bowel thickness is 3mm, and if it is exceeded more 
than 4 mm and it is considered as abnormal. 
If there is bowel wall thickening then further analyzing it whether  
 circumferential or asymmetrical;  
 regular or irregular walls,  
 signal characteristics in T2 weighted sequence – 
hyperintense suggesting active inflammation, hypointensity in T2 
suggesting fibrosis,  
 length of the involved segment, 
 any skip lesions 
 associated perienteric inflammation 
 fat stranding surrounding the involved segment of bowel 
 mesenteric phlegmon 
 interloop abscess 
 enlarged adjacent lymphnodes 
 luminal narrowing in the involved segment. 
 Other features like fibrofatty proliferation, enlarged lymph nodes, 
mesenteric vessel engorgement and ascites also noted down.  
 Contrast enhancement of the bowel wall noted; pattern of bowel 
wall enhancement- homogenous, heterogenous or stratified pattern noted. 
 Complications like enteroenteric fistula, enterocolic fistula, 
colocolic fistuala, perianal fistula and abscesses also noted. 
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 Bowel luminal narrowing is graded as 
 Absent  
 Mild – one third decrease in luminal distension 
 Moderate – two third decrease in luminal distension 
 Severe - total obstruction of the small bowel.  
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RESULTS 
TABLE1 
Normal Abnormal Total 
24 26 50 
48% 52% 100% 
 
 
 
 
 
Among 50 total subjects, 24 subjects have normal MR enterographic 
study and 26 subjects have abnormal MR enterography findings. That is 
52% are abnormal and 48% are normal. 
  
Normal
Abnormal
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TABLE 2 
DISEASES AMONG ABNORMAL SUBJECTS 
 
TYPE NUMBER 
PERCENTAGE 
AMONG TOTAL 
SUBJECTS 
Tuberculosis 9 18% 
Crohns disease 8 16% 
Large bowel 
disease 2 4% 
Carcinoid 1 2% 
Inconclusive 1 2% 
Ulcerative colitis 2 4% 
Fistula 1 2% 
Small bowel 
neoplasam 2 4% 
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DISEASES AMONG ABNORMAL SUBJECTS 
 
 
The table and chart explains that among 26 patients having 
abnormality, diagnosis made in MR enterography are tuberculosis 
intestine in 9 patients (18% of total subjects), diagnosis of crohn’s disease 
given in 8 patients (16% of total subjects), large bowel disease is found in 
two patients out of 50 subjects (4% of total subjects) , carcinoid tumour is 
found in one person (2% of total subjects), inconclusive in one person(2% 
of total subjects), diagnosis of ulcerative colitis given in two patients (4% 
of total subjects), fistula is seen in one patient (2% of total subjects), 
small bowel neoplasm seen in 2 patients (4% of total subjects). 
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TABLE 3 
Small bowel obstruction is present in twelve out of 26 abnormal 
patients  
 
Mild Moderate Severe 
7 4 1 
 
 
        
 
Among them mild obstruction is seen in seven patients (n=7), 
moderate obstruction is seen in four patients(n=4), and  severe 
obstruction  in one patient. (n=1).  
 
Mild
Moderate
Severe
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TABLE 4 
ADEQUACY OF BOWEL DISTENSION GRADING 
 
Grade 3 Grade 2 Grade 1 
29 18 3 
 
FIGURE: 
 
 
 
Among the 50 patients 29 patients have all of the bowel loops well 
distended ; 18 patients have most of the bowel loops well distended, few 
loops are unopacified; In 3 out of 50 patients most of the loops are less 
distended and less opacified. 
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TABLE 5 
SENSITIVITY AND SPECIFICITY OF MR 
ENTEROGRAPHY 
 
 
MRE 
HPE 
Total 
PRESENT ABSENT 
POSITIVE 24 2 26 
NEGATIVE 2 22 24 
TOTAL 26 24 50 
 
 
SENSITIVITY- 92.30% 
SPECIFICITY-91.66% 
 
26 patients who had abnormal findings in MR enterography, on 
follow up with scopy and HPE findings, MR enterography findings and 
HPE findings correlated in 24 patients. 
In two patients MR enterography showed findings but with negative 
HPE results. In two patients in whom MR enterography is normal but 
scopy showed findings with positive HPE results. 
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TABLE 6 
 
SENSITIVITY AND SPECIFICITY OF MR 
ENTEROGRAPHY IN DIAGNOSING CROHNS DISEASE 
 
 
MRE 
HPE 
Total 
PRESENT ABSENT 
POSITIVE 7 1 8 
NEGATIVE 2 40 42 
TOTAL 9 41 50 
 
 
SENSITIVITY- 77.77% 
SPECIFICITY-97.56% 
 
8 among 50 patients are diagnosed as crohn’s disease. 
Among these 8 patients, seven patients showed correlation with HPE 
and one patient had negative HPE results. 
2 patients out of remaining 42 subjects in whom MR enterography 
was normal but scopy and HPE findings are crohn’s disease. 
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DISCUSSION 
 
Small bowel pathology is detected in 26 patients (52%) and no 
significant abnormalities in24 (48%) patients.  
 
ILEOCEACAL TUBERCULOSIS: 
Nine patients small bowel wall thickening compatible with ileoceacal 
tuberculosis.  
 Out of these nine patients four patients had bowel wall 
thickening, lymphnode enlargement and ascities.  
 Three patients had bowel wall thickening and lymph node 
enlargement.  
 Two patients had only bowel wall thickening.  
 Seven out of nine patients had ceacal involvement.  
 Pulled up ceacum is seen in four patients.  
 Mesenteric inflammatory changes seen in four patients.  
 Peritoneal thickening and nodules seen in one patient. 
 Out of these nine patients only two patients had thoracic 
symptoms and findings. 
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CROHN’S DISEASE 
Small bowel wall abnormalities suggesting crohn’s disease is seen in 
eight patients  
 All patients are newly diagnosed. 
 Length of the involved segment varies between 2 to 15 cm. 
 More than one segment of bowel (skip lesions) seen in two 
patients.  
 Low to intermediate grade of small bowel obstruction is seen 
in three of the crohn’s patients. 
 Entero-cutaneous fistula is seen in one patient. 
 Perianal fistulas detected in 2 patients. 
 
LARGE BOWEL PATHOLOGY 
Two patients with lower g.i bleeding had normal small bowel findings 
and found to have pathology in the large bowel.  
 One patient had subtle asymmetric wall thickening in the 
rectum and later proved to be rectal adenocarcinoma with 
HPE. 
 Another patient had proliferative ceacal growth and proved to 
be ceacal adenocarcinoma with HPE. 
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ULCERATIVE COLITIS 
Two patients had features consistent with ulcerative colitis. 
Both patients have uniform rectal wall thickening with contrast 
enhancement  of  the wall with no perienteric inflammation of fat. 
Lesions are limited to the rectum with no small bowel lesions found in 
both patients. 
 
SMALL BOWEL NEOPLASM 
Small bowel neoplasm is found out in this study in two patients both of 
them have vague long term abdominal pain. One in the duodenum and 
another in the jejuna loop. Both the patients underwent surgery.   
 Duodenal lesion HPE came to be adenoma and 
 Jejunal lesion HPE is lymphoma. 
 
One patient had an infiltrating carcinoid of terminal ileum. 
One patient had inconclusive findings on MR enterography and patient 
was on follow –up. 
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SMALL BOWEL OBSTRUCTION 
Small bowel obstruction is present in twelve out of 26 patients with 
mild in seven patients (n=7), moderate in four patients(n=4), and  severe 
in one patient. (n=1).  
 
One patient in whom the enterography was found to be normal has 
perforation of duodenum one month after the study and got operated for 
that. 
         
Therapeutic strategy is altered in many patients who underwent 
MR enterography. 
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 Fast sequence 
 Sensitive to intraluminal 
flow voids 
 Poor evaluation of 
mesentery 
 
HASTE SEQUENCE 
 
CORONAL 
 
 
AXIAL 
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TruFISP SEQUENCE 
 
CORONAL 
 
 
AXIAL 
 
AXIAL 
 
  
 Fast 
 High contrast between 
small bowel lumen and 
bowel walls 
 Homogeneous 
endoluminal 
opacification   
 Good mesenteric 
anatomy (LAN, comb 
sign, vessels) 
 Susceptibility artifacts 
from intraluminal air  
 Chemical shift artifacts 
– black boundary 
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CORONAL T1 FAT SATURATED POST 
CONTRAST IMAGE 
 
 
 
 
 
 
  
Coronal T1 fat-saturated post-contrast image: 
normal bowel wall shows mild homogeneous 
enhancement 
 3 D spoiled gradient echo sequence 
 Sensitive to motion artifact 
 Bowel peristalsis is reduced by prior 
administration of spasmolytic 
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COMB’S SIGN 
 
 
 
 
 
  
74 
 
PERIANAL CROHN’S DISEASE 
 
 
 
 
Intersphincteric Fistula in patient with crohn’s disease. 
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CASE 1 CROHN’S DISEASE WITH PERIANAL FISTULA 
AND ABSCESS 
 
 
 
 
 
 
 
 
 
Coronal contrast enhanced T1 
weighted MR  shows terminal 
ileum showing increased wall 
thickening and contrast 
enhancement- terminal ileitis 
suggestive of crohn’s disease. 
Axial contrast enhanced T1 
weighted MR image in the 
same patient shows 
peripherally enhancing abscess 
with surrounding fat stranding 
and transsphincteric fistula. 
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CASE 2 CROHN’S DISEASE 
 
 
 
 
 
 
 
 
 
Axial T2 weighted MR shows 
long segment moderate ileal 
wall thickening with luminal 
narrowing. Mucosa is 
edematous and T2 
hyperintense. 
Axial unenhanced T1 
weighted image shows long 
segment wall thickening of 
distal ileum. The involvement 
is transmural with surrounding 
fat stranding. 
Axial T1 weighted post 
contrast MR shows significant 
contrast enhancement 
suggesting active disease 
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CASE 3 CROHN’S DISEASE 
 
 
 
 
 
 
  
Axial T2 weighted MR shows 
conglomeration of distal ileal 
loops in right lower quadrant. 
Axial T1 weighted post 
contrast MR shows intense 
contrast enhancement with 
surrounding fat stranding with 
adherence of bowel loops to 
the bladder wall. 
Axial T1 weighted post 
contrast MR shows marked 
luminal narrowing with combs 
sign suggesting active 
inflammation. 
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CASE 4 CROHN’S DISEASE 
 
 
 
 
 
 
 
 
 
Axial T1 weighted post contrast 
subtracted MR shows multifocal 
ileal thickening with intense 
contrast enhancement and mild 
luminal narrowing 
Axial T1 weighted post 
contrast MR shows increased 
fat between the bowel loops – 
fibrofatty proliferation 
Axial T1 weighted post contrast 
MR shows increased mesenteric 
vascularity perpendicular to the 
bowel wall resembling teeth of 
the comb – combs sign 
suggesting active crohns 
disease. 
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CASE 5 CROHN’S DISEASE 
 
 
 
 
 
 
Coronal Tru Fisp image showing 
moderate terminal ileal and 
ceacal thickening with skip 
lesions at ascending colon at the 
hepatic flexure level. 
Axial Tru Fisp image showing 
moderate terminal ileal and 
ceacal thickening with skip 
lesions at ascending colon at 
the hepatic flexure level. 
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CASE 6 ULCERATIVE COLITIS 
  
 
 
 
 
  
Axial T1 weighted image of 
the same patient shows diffuse 
wall thickening of the sigmoid 
colon . 
Axial Fat sat T2 weighted 
image showing wall 
thickening of sigmoid colon 
and T2 hyperintensity of the 
mucosa. Adjacent fat appears 
normal. 
Axial contrast enhanced T1 
weighted image of the same 
patient contrast enhancement 
of the inflammed mucosa. 
Enhancement is mainly 
limited to the mucosa and the 
surrounding fat appears 
normal. 
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CASE 7 ULCERATIVE COLITIS 
 
 
 
 
 
 
 
 
Axial Tru Fisp image showing 
uniform long segment wall 
thickening of the rectum and 
sigmoid colon. Wall 
thickening is minimal and 
looking like prominence of 
black boundary artifact. 
Coronal Tru Fisp image 
showing uniform wall 
thickening of the rectum with 
surrounding fat appears 
normal. 
Coronal T1 contrast enhanced 
image showing uniform 
mucosal enhancement of rectal 
mucosa. 
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CASE 8 ILEO CEACAL TUBERCULOSIS 
 
 
 
 
 
 
 
Axial TruFisp image showing 
moderate wall thickening of 
terminal ileum ileoceacal 
junction and ceacum 
Coronal TruFisp image 
showing moderate wall 
thickening of ceacum and 
ileoceacal junction 
Coronal contrast enhanced T1 
weighted image showing mild 
enhancement of the bowel at 
ileoceacal region 
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CASE 9 ILEO CEACAL TUBERCULOSIS 
 
 
 
 
 
 
 
Axial TruFisp weighted image 
showing long segment 
circumferential wall 
thickening of ileal loops with 
ascities and few  adjacent 
enlarged lymph nodes. 
Coronal TruFisp weighted 
image showing long  
segment circumferential wall 
thickening of ileal loops and 
ceacum with ascities and 
enlarged mesenteric lymph 
nodes. 
Axial TruFisp weighted  
image showing long segment 
circumferential wall 
thickening of ileal loops with 
ascities and few adjacent 
enlarged lymph nodes. 
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CASE 10 ILEO CEACAL TUBERCULOSIS 
 
 
 
 
 
 
 
 
Axial TruFisp weighted image 
showing irregular 
circumferential wall 
thickening of ileal loops with 
moderate luminal narrowing 
with adjacent lymph nodes. 
Axial TruFisp weighted image 
showing multiple mesenteric 
lymphnodes 
Axial TruFisp weighted image 
showing ascities and 
incidental dermoid in left 
ovary 
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CASE 11 CEACAL GROWTH 
 
 
 
 
 
 
 
 
  
Coronal TruFisp weighted 
image showing gross 
thickening of ceacum and 
ascending colon causing 
marked luminal narrowing. 
Axial TruFisp weighted image 
showing gross thickening of 
ceacum and ascending colon 
causing marked luminal 
narrowing. 
Axial TruFisp weighted image 
showing gross thickening of 
ceacum and ascending colon 
causing marked luminal 
narrowing. 
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CASE 12 RECTAL GROWTH 
 
  
 
   
 
 
 
 
 
Patient who had obsure 
gastrointestinal bleeding 
shows focal asymmetrical wall 
thickening of rectum and on 
follow up with scopy and HPE  
came to be rectal 
adenocarcinoma 
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CASE 13 DUODENAL ADENOMA 
 
 
 
 
 
 
 
 
  
Axial truFisp image showing 
3.2 x 2.5 cm well defined 
lesion in the third part of 
duodenum.  
Coronal truFisp image 
showing the same lesion in the 
third part of duodenum with 
peripheral flow of oral 
contrast. 
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CASE 14 JEJUNAL LYMPHOMA 
 
 
 
 
 
 
CASE 15 ENTERO ENTERIC FISTULA 
 
 
 
 
 
Axial TruFisp image showing 
concentric mural thickening of 
jejunum suggestive of jejuna 
lymphoma. HPE came as B cell 
lymphoma 
Patient who had apast history 
of bowel surgery showing 
adhesions and entero enteric 
fistula causing luminal 
narrowing and enhancement of 
the bowel wall. 
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MR ENTEROGRAPHY 
 
In this study, it is shown that MR enterography is better imaging tool 
for small bowel visualization. The advantages of MR enterography that 
are emphasized in this study are superior tissue characterization, adequate 
distension is available in most of the patients, extramural lesions are 
detected better, transmural involvement is clearly shown and evaluation 
of disease activity also demonstrated, and importantly without using 
ionizing radiation. 
 
In most of the studies in literature sensitivity and specificity of MR 
enterography is equal to or higher than CT enterography. The sensitivity 
and specificity of MR enterography in diagnosing small bowel disease in 
this study is 92.30% and 91.66% respectively. This value is clearly higher 
than sensitivity(88%) and specificity (88%) obtained by Foriano et al 
(59). The sensitivity and specificity obtained in this study is higher or 
equal than most of the studies in the literature.  
 
The sensitivity for MR enterography in diagnosing crohns in this 
study is 77.77% and specificity of MR enterography in crohns is 97.56%. 
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The sensitivity is lower than overall sensitivity because two patients 
that was reported as normal in MR enterography was diagnosed to have 
crohns disease in scopy and confirmed with HPE. This may be due to the 
early mucosal change that are not visualized in MR enterography. 
 
As the protocol is simple, reliable and reproducible, MR 
enterography will become the first line modality in future for small bowel 
visualization and for knowing the extent of the disease and for follow up. 
 
MR IMAGING OF ILEOCEACAL TUBERCULOSIS 
 Long segment wall thickening of ascending colon, terminal 
ileum with pulled up caecum, paraaortic lymphadenopathy 
and ascites, 
 Asymmetrical wall thickening of the caecum and terminal 
ileum, low density lymph nodes in the paracaval, paraaortic, 
aortocaval region. 
 Terminal ileum thickening with mesenteric inflammatory 
changes. 
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DIFFERENTIATING FEATURES OF ILEOCECAL 
TUBERCULOSIS AND CROHNS DISEASE:- 
 
TUBERCULOSIS FEATURES: 
 Asymmetric wall thickening, irregular, 
 No creeping fat, 
 Omental and peritoneal thickening, 
 Enlarged lymph nodes with low-density centers. 
 
CROHN’S DISEASE FEATURES 
 Circumferential bowel wall thickening +/- mural stratification, 
 Creeping fat (abnormal quantity of mesenteric fat), 
 Prominent mesenteric vessels indicating hyperemia, 
 Normal omentum and peritoneum 
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MR IMAGING OF CROHNS DISEASE 
In this study it is shown that eight patients with crohns disease is 
diagnosed out of 50 patients with small bowel symptoms. Sensitivity 
obtained in this study in diagnosing crohn’s is 77.77% which is lower 
than the studies in the literature. Specificity in this study is 97.56% which 
is higher than most of the studies. 
Studies done by albert et al, reiber et al, umaschaden et al, Bernstein 
et al compared MR enterography sensitivity and specificity in diagnosing 
crohns disease with multiple other modalities. From these studies they 
have concluded that MR has excellent sensitivity and specificity for 
detecting active inflammation. MR is far better than conventional barium 
follow through and conventional enteroclysis. (28, 39, 40, 41).  
Bernstein CN et al, Schmidt S et al, Rieber A et al showed that 
differentiating between inflammatory strictures and fibrostenotic 
strictures is well made out in MR enterography (28,41,42).  
Gourtsoyiannis et al and Prassopoulos P et al in their study said that 
eventhough MRI is best in detecting mural, transmural, extraluminal 
disease; subtle mucosal changes cannot be picked up by MRI due to less 
spatial resolution. They also added that these mucosal changes are better 
shown in barium studies. This is considered as a significant limitation for 
MRI in diagnosing early stage of crohn’s disease.  (43, 44). 
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There is no enough study done so far for comparison of MR and CT 
enterography. Horsthuis et al (45) and Siddiki et al (46), both did a meta 
analysis study and showed that there is no difference in sensitivity 
between both modalities and both has similar accuracy in identifying and 
demonstrating the disease. 
 
ACTIVE SIGNS OF CROHN’S DISEASE IN MRI 
 Bowel wall thickening, 
 Increased mucosal enhancement – earliest sign, 
 Comb sign - increased mesenteric vascularity, 
 Mucosal ulcerations,  
 Perienteric inflammation,  
 High signal intensity in the bowel wall in T2 sequence. 
 Penetrating disease & fistulas  
 Reactive lymphadenopathy  
 Bowel obstruction. 
     Even without bowel wall thickening mucosal hyperenhancement  
is considered as earliest signs of active crohns. This statement is 
substantiated by the study done by Choi D et al and Del Vescova et al 
(47,48).  
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WALL ENHANCEMENT PATTERNS 
 Uniform homogenous enhancement of bowel wall 
 Stratified pattern of enhancement- mucosal enhancement with 
submucosal edema 
 Target pattern –addition to stratified pattern serosal 
enhancement giving alternate hyper and hypo intense layers 
giving target appearance. 
In this study wall enhancement is seen in all the patients diagnosed as 
crohn’s disease. Stratified pattern is seen in one patient and target pattern 
is seen in one patient and remaining all has homogenous enhancement 
pattern. 
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SMALL BOWEL MASSES 
Only three patients out of 50 patients enrolled in the study showed 
small bowel masses. There is very little studies available for role of MR 
imaging in small bowel masses. 
 
 One study done by Caspari r et al in 2004 compared efficacy of 
MRI and capsule endoscopy in the detection of polyps(51). The study 
mentioned no significant difference between MRI and capsule endoscopy 
in detecting polyps (larger size) in small intestine but MRI is superior in 
localisising its location in the small bowel. 
 
Even CT can be utilized for detecting small bowel masses but 
contrast enhancement of masses are different. Polyps will be missed in 
suboptimal distension of bowel loops. Some of the mass lesions and 
polyps are isodense to the bowel wall hence difficult in detecting in CT. 
Some polyps or masses are hyperenhancing and with oral contrast 
agents that are brighter in CT, lesions might be missed, these lesions are 
better shown in CT if neutral oral contrast is given. 
In MRI biphasic oral contrast is used hence this limitation seen in 
CT is overcome in MRI. 
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SMALL BOWEL OBSTRUCTION 
In our study small bowel obstruction is seen in twelve out of 26 
patients with abnormalities in MR enterography. Very little data in the 
literature about the dedicated study of role in MRI in detecting small 
bowel obstruction. 
 
Beall DP et al and Low RN et al done a study about the role of MRI 
in diagnosing high grade obstruction in acute condition and depicted that 
MRI has a very high sensitivity for detecting acute bowel obstruction and 
differentiating its causes (36,52). 
 
In the case of low grade obstruction, the imaging methods are 
different. Routine cross sectional CT or MRI may not be able to detect 
the abnormalities in patients with intermittent low grade obstruction. And 
it is mainly because of the suboptimal distension of the bowel loops. 
 
Many studies showed that CT or MR enteroclysis is more superior in 
detecting lesions in low grade bowel obstruction. Most of the cases low 
grade obstruction is mainly because of adhesions and focal strictures. In 
the CT enteroclysis or enterography the main disadvantage is unable to 
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differentiate between contracting bowel loop and focal wall thickening or 
stricture. For that repeat study or real time imaging is needed as 
contracting segment due to peristalsis will be reverted back to normal. 
But repeat CT examination will result in increase in radiation dose. MRI 
will be helpful in these patients and there is advent of cine MRI which 
readily differentiates between these two conditions. 
 
PERIANAL CROHN'S DISEASE  
In our study perianal fistulas and abscess is seen in two patients with 
crohn’s disease. For assessment of fistula MRI is far superior than any 
other modalities as it is vital to give the tracts relation with internal 
sphincter as it will change the treatment modality. 
 
Unlike small bowel imaging in crohns which have a lot of debate in 
the superiority of the modality, MRI is accepted as the modality in 
imaging perianal fistula by almost everyone. Sensitivity for MRI in 
imaging perianal fistulas is 80% and accuracy of more than 90% (53,54). 
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St. James University grading for perianal fistula in MRI is widely 
acceptable and very well surgically correlated (55). CT scans are less 
useful in imaging perianal crohns as sphincter complex cannot be better 
depicted in CT. Another modality that can be used for imaging perianal 
fistula are endoscopic ultrasound. 
In MRI recent addition of diffusion weighted sequence is better 
additive and alternative for T2 weighted and contrast sequence. Ziech, 
Felt-Bersma and Stoker  done a study in perianal fistula and proved its 
validity (56). 
 
MRI IN ULCERATIVE COLITIS: 
 
 
Crohn’s and ulcerative colitis both are inflammatory bowel disease. 
There are lots of studies in literature available in assessing efficacy and 
sensitivity for MRI in crohn’s disease. But only very few studies  
available for assessing efficacy of MRI in ulcerative colitis. This 
condition arise because of the basic difference between ulcerative colitis 
and crohn’s disease. 
 
More than 95% of ulcerative colitis involves mainly the rectum and 
usually follows the predictable course from left side of colon then 
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transverse and right side of colon. But in crohn’s any part of the bowel 
can be involved and has highly unpredictable and discontinuous course. 
 
In ulcerative colitis distal ileum is involved only in the consequence 
of pancolitis, isolated ileal involvement not occurs with ulcerative colitis 
 
In crohn’s disease the main area of involvement is mucosal 
inflammation of distal ileum. Ulcerative colitis is mainly mucosal 
disease, extramural inflammation is usually not seen in this disease. 
Perienteric fats are normal in ulcerative colitis. 
 
SIGNS OF ULCERATIVE COLITIS ARE: 
 Mild to moderate bowel wall thickening 
 Loss of haustrations 
 Presacral space widening. 
 
COMPLICATIONS OF ULCERATIVE COLITIS: 
 Toxic megacolon 
 Stricture  
 Massive bleeding 
 Colorectal cancer 
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 Perianal complications, abscess, fistulas not usually seen in 
ulcerative colitis. 
Diagnosing crohn’s is more tough than diagnosing ulcerative colitis. 
In this study two patients showed features of ulcerative colitis which 
shows uniform thickening of bowel wall with contrast enhancement with 
fat around the lesion appears normal. Thus it is a mucosal disease with 
predominant rectal involvement so endoscopy and biopsy is easier with 
ulcerative colitis as it mainly involves the colon and small bowel is rarely 
involved. Hence cross sectional imaging is not playing major role in 
diagnosing ulcerative colitis. 
 
But in crohn’s it is a transmural disease with mainly small bowel 
involvement and with many complications , so cross sectional imaging 
plays an important role in crohn’s disease. 
 
Eventhough ulcerative colitis is better diagnosed with scopy, there 
are conditions like where MRI is a very good alternative for endoscopy . 
 Contraindications for endoscopy 
 High morbidity for the procedure 
 Refusal by the patients 
 Incomplete endoscopic procedure 
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CONCLUSION 
 
MR enterography is of major benefit and problem solving diagnostic 
modality in patients with suspected small bowel disease. 
 
Especially young patients with chronic small bowel symptoms, MR 
enterography is modality of choice as it has no radiation. 
 
In this study it is well made out that study protocol is simple and 
acceptable and patient’s compliance to the study is far better. 
 
MR enterography can be used as a screening tool for diagnosing 
small bowel disease as most of the patients are refusing invasive 
procedures as a screening modality. 
 
In this MR enterography  various manifestations of crohn’s disease 
and intestinal tuberculosis is seen and it is used as a primary tool to 
evaluate presence of the disease and also the extent of the disease.  
 
In cases where colonoscopy did not reach the terminal ileum, MR 
enterography may help to determine the optimal therapeutic strategy. 
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Disease activity can be predicted by MR enterography by looking at 
bowel edema and contrast enhancement of bowel wall and lymph nodes.  
        
In this study various small bowel diseases are detected and some of 
the large bowel diseases that presents with small bowel symptoms also 
found out. The range of indications for MR enterography became wide 
and also including small bowel obstruction, motility disorders, persistent 
diarrhea and abdominal pain, and a problem solving tool when other 
imaging modalities cannot diagnose a small bowel abnormality. 
 
Thus, MR enterography is an excellent modality that has adequate 
transmural visualization of the small bowel and providing sufficient 
information about etiology, distribution, exact location, activity of the 
disease, and complications of the disease. Thus, MR enterography will be 
the method of choice for the noninvasive evaluation of small bowel 
disorders. 
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ROLE OF MR ENTEROGRAPHY IN SMALL BOWEL 
DISEASES 
 
Institution : Barnard Institute of Radio Diagnosis, 
Madras Medical College, 
Chennai-600 003.  
Name :     Date    : 
Age :     IP No    : 
Sex :     Project Patient No  : 
The details of the study have been provided to me in writing and 
explained to me in my own language. 
I confirm that I have understood the above study and had the opportunity 
to ask questions. 
I understood that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without the 
medical care that will normally be provided by the hospital being 
affected. 
I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s). 
I have been given an information sheet giving details of the study. 
I fully consent to participate in the above study Role Of MR 
Enterography In Small Bowel Diseases. 
 
__________________________ 
Name of the Subject 
_____________ 
Signature 
___________ 
Date 
   
 
 
 
 
PROFORMA 
Name: 
Age and sex: 
IP/ OP number: 
Ward number: 
Address: 
Contact number: 
 
HISTORY: 
1. Diarrhea with duration 
2. Blood in stools 
3. Abdominal pain  
4. Fever 
5. Vomiting 
6. Previous investigations 
7. Any drug allergy 
 
PAST HISTORY: 
 
 
INVESTIGATION: 
 
 
1. Ultrasound abdomen 
2. Upper GI endoscopy findings if any 
3. Lower GI endoscopy findings if any 
4. Serum creatinine 
5. Blood urea 
6. Hemoglobin  
7. ESR 
 
MR ENTEROGRPAHY FINDINGS: 
FOLLOW UP: 
HPE FINDINGS: 
 
 
 
 
 
 
 
  
 
 
MASTER CHART 
S. 
NO NAME 
AGE/ 
SEX 
CLINICAL 
HISTORY 
MR 
ENTEROGRPAHY 
FINDINGS 
FOLLOW UP 
WITH HPE 
1 Anjalai 35/F 
Weight loss, lower 
abdominal pain, 
diarrhea for past one 
month 
Long segment 
ileoceacal 
thickening with 
ascities with 
multiple mesenteric 
node enlargement 
s/o ileoceacal 
tuberculosis 
Tuberculosis 
2 Perumal 37/M 
Lower adominal 
pain with CT 
showing subtle wall 
thickening in ileal 
loops 
Normal Normal 
3 Lakshmipathy 42/M 
Abdominal pain and 
distension ? 
subacute intestinal 
obstruction 
Normal Normal 
4 Prakash 44/M Unknown cause of lower gi bleeding 
Skip lesions with 
bowel mucosal 
enhancement -
Crohn’s disease 
Crohn’s disease 
5 Balashankar 35/M Lower abdominal pain 
Irregular distal ileal 
thickening with 
surrounding fat 
stranding- 
Tuberculosis 
Tuberculosis 
6 Balaji 18/M Chronic lower abdominal pain Normal Normal 
7 Pradeepa 32/F Lower abdominal pain 
Bowel wall 
thickening in ileum 
, colon with 
perianal fistula 
Crohn’s disease 
Crohn’s disease 
8 Xavier 37/M 
Abdominal pain and 
vomiting for 2 
months 
Normal Normal 
9 Lakshmanan 18/M Multiple perianal fistula 
Crohn’s disease and 
multiple fistula in 
ano and perianal 
abscess 
Crohn’s disease 
10 Nagammal 26/F 
Abdominal 
distension and pain 
for 3 months 
Gross ileum and 
ceacal thickening 
with ascities and 
multiple mesenteric 
nodes and 
incidental dermoid 
in left ovary- 
Tuberculosis 
Tuberculosis 
11 Vishnu priya 39/F History of small Entero enteric Entero enteric 
 
 
bowel surgery for 
vasculitis and 
segmental gangrene 
of small bowel  
Fistula Fistula 
12 Murugaiyan  50/M 
Bleeding P/R for 3 
months with 
colonoscopy normal  
Mild asymmetrical 
thickening noted in 
the rectum- rectal 
growth 
Repeat 
colonoscopy 
confirmed the 
findings- HPE- 
Adenocarcinoma 
13 Krishnaveni 50/F 
Chronic right ilac 
fossa pain with 
diarrhea ?intestinal 
tuberculosis 
Normal Normal 
14 Nirmala 35/F ?subacute intestinal obstruction Normal Normal 
15 Sathya 21/F Vague abdominal pain 
Well defined T2 
hyperintense lesion 
in the third part of 
duodenum- Small 
bowel neoplasm 
HPE- Duodenal 
adenoma 
16 Rajesh 33/M Chronic abdominal pain 
Asymmetrical wall 
thickening of 
terminal ileum and 
ceacum- 
Tuberculosis 
Tuberculosis 
17 Paranthaman 36/M 
Frequent diarrhea 
more than 4 times 
per month 
?infectious enteritis 
Normal Normal 
18 Jayalakshmi 35/F 
Diarrhea on and off 
for 2 months with 
bleeding P/R 
Normal Normal 
19 Kannan 35/M 
Multiple perianal 
fistula ? crohn’s 
disease 
Normal Normal 
20 Anitha 22/F Chronic diarrhea 
Smooth bowel wall 
thickening with 
skip lesions 
Crohn’s disease 
21 Prakash  55/M ? subacute intestinal obstruction 
Target pattern of 
bowel 
enhancement- 
Crohn’s disease  
Crohn’s disease 
22 Gowri 50/F 
Past history of 
appendicectomy 
with chronic right 
iliac fossa pain ? 
tuberculosis  
Normal Normal 
23 Sundarammal 52/F ?low grade small bowel obstruction Normal Normal 
24 Nagalingam 27/M ? inflammatory bowel disease 
Terminal ileal 
thickening with 
mucosal edema 
Crohn’s disease 
25 Kuppu gownder 40/M 
Altered bowel habits 
for one month Normal Normal 
 
 
26 Shanthi 25/F 
Abdominal pain and 
constipation for one 
month 
Normal Normal 
27 Venkatesan 33/M Diarrhea on and off for 2 months 
Bowel wall 
thickening with 
homogenously 
enhancing terminal 
ileum with skip 
lesions Crohn’s 
disease 
HPE- 
nonspecific 
enteritis 
28 Susan 30/F Anal fistula for evaluation Crohn’s disease Crohn’s disease 
29 Muthupandi 36/M ?subacute intestinal obstruction Normal Normal 
30 Sami 44/M Abdominal pain on and off Crohn’s disease Crohn’s disease 
31 Krishnan  29/M 
Lower abdominal 
pain and diarrhea for 
past 2 months 
Normal 
Mucosal edema 
in terminal 
ileum HPE- 
crohn’s 
32 Punitha  36/F Bloody diarrhea for 1 month 
Stratified contrast 
enhancement of 
ileum - Crohn’s 
disease 
Crohn’s disease 
33 shini 33/F Diarrhea on and off for 3 months Normal Normal 
34 Veda vidya 26/F 
Altered bowel habits 
? inflammatory 
bowel disease 
Normal Normal 
35 Lakshmi 70/F 
Vague lower 
abdominal pain for 3 
months 
Subtle thickening 
of terminal ileum 
and ileo ceacal 
junction- 
tuberculosis 
Tuberculosis 
36 Rajkumar 37/M 
Abdominal pain for 
2 months ? 
inflammatory bowel 
disease 
Gross irregular 
circumferential 
wall thickening in 
ceacum. Terminal 
ileum appears 
normal- Ceacal 
growth 
HPE – Ceacal 
adenocarcinoma 
37 Balakumaran 35/M 
Ultrasound abdomen 
showing  wall 
thickening in right 
ilac fossa 
Normal Normal 
38 Munij 14/M Fever, unexplained weight loss 
Ileoceacal 
thickening - 
tuberculosis 
Tuberculosis 
39 Vijayasekaran 50/M ?intestinal tuberculosis Normal Normal 
40 Elangovan 55/M 
Abdominal pain , 
vomiting for 1 
month 
Ileoceacl 
thickening for a 
length of 5 cm 
tuberculosis 
Tuberculosis 
 
 
41 Vidhya  32/F Chronic diarrhea 
Suspicious 
thickening of 
ileocecal junction- 
Inconclusive 
Inconclusie 
scopy and HPE 
findings. Case 
on follow up. 
42 Venkata prasanna 30/M 
?inflammatory 
bowel disease Normal Normal 
43 Nazeema begum 36/F 
Bloody diarrhea for 
3 months evaluated 
for that in private 
hospital ? ulcerative 
colitis 
Rectal 
circumferential 
wall thickening 
with contrast 
enhancement 
Ulcerative Colitis 
Ulcerative 
Colitis 
44 Shameem Taj 29/F 
Evaluated for 
arthritic pain and 
bilateral sacroilitis 
Circumferntial 
rectal wall 
thickening with 
contrast 
enhancement -
Ulcerative Colitis 
Ulcerative 
Colitis 
45 Surya 20/F 
Lower abdominal 
pain for 4 months on 
and off 
Normal 
Mucosal 
thickening in 
distal ileum with 
mucosal edemal 
– HPE-Crohn’s 
46 Patchaiammal 22/F 
Diarhoea on and off 
with lower gi 
bleeding 
Subtle thickening at 
ileoceacal junction- 
Tuberculosis 
Tuberculosis 
47 Parvatham 46/F Diarrhea on and off with bleeding P/R Normal Normal 
48 Paremeshwar 30/M Abdominal pain on and off 
Carcioid tumour 
distal ileum 
Patient 
underwent 
surgey HPE- 
carcinoid  
49 Krishna Kumar 30/M 
Non specific 
abdominal pain with 
diarrhea 
Normal Normal 
50 Selvam 42/M Right lower quadrant pain Normal Normal 
 
 
 
